Resultados de Procura por Autor :: APM

1

Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years por Varinder Kaur, Arjun Swami, Daisy Alapat, Al - Ola Abdallah, Pooja Motwani, Laura F. Hutchins, Yogesh Jethava

Publicado 2017

Ligazón do recurso Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
2

Conditioning regimens for allogeneic hematopoietic stem cell transplants in acute myeloid leukemia por Yogesh Jethava, Simona Sica, Bipin N. Savani, Francisco Socola, Madan Jagasia, Mohamad Mohty, Arnon Nagler, Andrea Bacigalupo

Publicado 2017

Ligazón do recurso
Revisão

Engadir a favoritos

Gardado en:
3

Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma por Reinaldo Franqui-Machin, Mu Hao, Hua Bai, Zhimin Gu, Xin Zhan, Hasem Habelhah, Yogesh Jethava, Lugui Qiu, Ivana Frech, Guido Tricot, Fenghuang Zhan

Publicado 2018

Ligazón do recurso Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
4

Alteration of mitochondrial biogenesis promotes disease progression in multiple myeloma por Xin Zhan, Wenjie Yu, Reinaldo Franqui-Machin, Melissa L. Bates, Kalyan Nadiminti, Huojun Cao, Brad A. Amendt, Yogesh Jethava, Ivana Frech, Fenghuang Zhan, Guido Tricot

Publicado 2017

Ligazón do recurso Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
5

Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120) por Rashid Z Khan, Madhav V. Dhodapkar, Adam Rosenthal, Christoph Heuck, Xanthos Papanikolaou, Pingping Qu, Frits van Rhee, M. Zangari, Yogesh Jethava, Joshua Epstein, Shmuel Yaccoby, Antje Hoering, John Crowley, Nathan Petty, Clyde Bailey, Gareth J. Morgan, Bart Barlogie

Publicado 2015

Ligazón do recurso Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
6

Inhibiting MEK in MAPK pathway-activated myeloma por Christoph Heuck, Yogesh Jethava, Rashid Z Khan, Frits van Rhee, Maurizio Zangari, Shweta S. Chavan, Kelly R. Robbins, Scott E. Miller, Aasiya Matin, Meera Mohan, Siraj M. Ali, P. J. Stephens, Jeffrey S. Ross, V.A. Miller, Faith E. Davies, Bart Barlogie, Gareth J. Morgan

Publicado 2015

Ligazón do recurso Ligazón do recurso
Carta

Engadir a favoritos

Gardado en:
7

Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma por Minjie Gao, Hua Bai, Yogesh Jethava, Yujie Wu, Yuqi Zhu, Ye Yang, Jiliang Xia, Huojun Cao, Reinaldo Franqui-Machin, Kalyan Nadiminti, Gregory S. Thomas, Mohamed E. Salama, Peter Altevogt, Gail A. Bishop, Michael H. Tomasson, Siegfried Janz, Jumei Shi, Lijuan Chen, Ivana Frech, Guido Tricot, Fenghuang Zhan

Publicado 2019

Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
8

ELRANATAMAB, A B-CELL MATURATION ANTIGEN-CD3 BISPECIFIC ANTIBODY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED FOLLOW UP AND BIWEEKLY ADMINISTRATION FROM THE MA... por Mohamad Mohty, Michael H. Tomasson, Bertrand Arnulf, Nizar J. Bahlis, Martin Prince, Rubén Niesvizky, P Rodrgue-Otero, J Martine-Lopez, Guenther Koehne, Yogesh Jethava, Afshin Eli Gabayan, Don A. Stevens, Ajay K. Nooka, Noopur Raje, S Iida, Eric Leip, U. Conte, Akos Czibere, Andrea Viqueira, Vivian Blunk, Alexander M. Lesokhin

Publicado 2023

Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
9

$Efficacy and Safety of Elranatamab in Patients with Relapsed/Refractory Multiple Myeloma Naïve to B-Cell Maturation Antigen (BCMA)-Directed Therapies: Results from Cohort a of the Magnetismm-3 Study$

Efficacy and Safety of Elranatamab in Patients with Relapsed/Refractory Multiple Myeloma Naïve to B-Cell Maturation Antigen (BCMA)-Directed Therapies: Results from Cohort a of the... por Nizar J. Bahlis, Michael H. Tomasson, Mohamad Mohty, Rubén Niesvizky, Ajay K. Nooka, Salomon Manier, Christopher Maisel, Yogesh Jethava, Joaquín Martínez‐López, H. Miles Prince, Bertrand Arnulf, Paula Rodríguez‐Otero, Guenther Koehne, Cyrille Touzeau, Noopur Raje, Shinsuke Iida, Marc‐Steffen Raab, Eric Leip, Sharon T. Sullivan, Umberto Conte, Andrea Viqueira, Alexander M. Lesokhin

Publicado 2022

Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
10

$Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results$

Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results por Alexander M. Lesokhin, Michael H. Tomasson, Bertrand Arnulf, Nizar J. Bahlis, H. Miles Prince, Rubén Niesvizky, Paula Rodríguez‐Otero, Joaquín Martínez‐López, Guenther Koehne, Cyrille Touzeau, Yogesh Jethava, Hang Quach, Julien Depaus, Hisayuki Yokoyama, Afshin Eli Gabayan, Don A. Stevens, Ajay K. Nooka, Salomon Manier, Noopur Raje, Shinsuke Iida, Marc S. Raab, Emma Searle, Eric Leip, Sharon T. Sullivan, Umberto Conte, Mohamed Elmeliegy, Akos Czibere, Andrea Viqueira, Mohamad Mohty

Publicado 2023

Ligazón do recurso Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en:
11

Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis por Carla Casulo, Jonathan W. Friedberg, Kwang Woo Ahn, Christopher R. Flowers, Alyssa DiGilio, Sonali M. Smith, Sairah Ahmed, David J. Inwards, Mahmoud Aljurf, Andy I. Chen, Hannah Choe, Jonathon B. Cohen, Edward A. Copelan, Umar Farooq, Timothy S. Fenske, César O. Freytes, Sameh Gaballa, Siddhartha Ganguly, Yogesh Jethava, Rammurti T. Kamble, Vaishalee P. Kenkre, Hillard M. Lazarus, Aleksandr Lazaryan, Richard F. Olsson, Andrew R. Rezvani, David A. Rizzieri, Sachiko Seo, Gunjan L. Shah, Nina Shah, Melham Solh, Anna Sureda, Basem M. William, Aaron Cumpston, Andrew D. Zelenetz, Brian K. Link, Mehdi Hamadani

Publicado 2017

Ligazón do recurso
Artigo

Engadir a favoritos

Gardado en: